SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-20-000084
Filing Date
2020-04-14
Accepted
2020-04-14 17:12:32
Documents
17
Period of Report
2020-04-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a202004148k.htm   iXBRL 8-K 47904
2 EXHIBIT 1.1 a202004148kexhibit11.htm EX-1.1 309485
3 EXHIBIT 5.1 a202004148kexhibit51.htm EX-5.1 18237
9 mblogoa08.gif GRAPHIC 4449
  Complete submission text file 0000819050-20-000084.txt   590333

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20200414.xsd EX-101.SCH 4436
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbi-20200414_cal.xml EX-101.CAL 617
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbi-20200414_def.xml EX-101.DEF 1467
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20200414_lab.xml EX-101.LAB 27263
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20200414_pre.xml EX-101.PRE 14107
18 EXTRACTED XBRL INSTANCE DOCUMENT a202004148k_htm.xml XML 4695
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 20791910
SIC: 2836 Biological Products, (No Diagnostic Substances)